IVF Success Rates in Cyprus by Age: 2026 Patient Guide
Understand how IVF success rates are reported, how age affects treatment outcomes, and what patients should compare when considering IVF in Cyprus or Istanbul.
Meva Clinic provides medically guided IVF pathways through specialist fertility teams and partner institutions in Istanbul and Northern Cyprus. Standard IVF/ICSI assessment and treatment may be arranged through a JCI-accredited partner hospital in Istanbul, while selected donor-assisted or legally specific fertility options may be coordinated through a specialist partner fertility centre in Northern Cyprus. The appropriate location is determined after medical and legal suitability review. Patients considering treatment in Northern Cyprus can review our IVF Cyprus Special care pathway.
Ready to start your journey?
Free consultation · 24h response
Understanding IVF Success Rates: Pregnancy Rate vs. Live Birth Rate
When researching IVF outcomes, distinguishing between clinical endpoints and initial diagnostic tests is essential. A positive hCG blood test can indicate a biochemical pregnancy. A clinical pregnancy is generally confirmed by ultrasonographic visualisation of one or more gestational sacs. A live-birth rate measures the delivery of at least one live-born infant. Rates may be calculated per cycle started, per egg retrieval, or per embryo transfer. Key clinical variables—including female age, ovarian reserve (AMH/AFC), embryo morphological quality, sperm health parameters, and endometrial receptivity—profoundly influence individual outcomes.
How IVF Success Rates Vary by Female Age & Treatment Method
Age at egg collection is one of the most important factors affecting IVF outcomes when using a patient’s own eggs. The latest HFEA 2024 UK registry data illustrates the effect of age on treatment outcomes. Among IVF treatments using patients’ own eggs, the average birth rate was 38% per embryo transferred for patients aged 18–34, compared with 8% for patients aged 43–44. The overall UK average was 30%. These figures are UK regulatory benchmarks—not Cyprus or Meva Clinic success rates—and cannot predict an individual patient’s outcome. Note that 2024 outcome data is preliminary and subject to final validation.
In donor-egg treatment, outcomes are more closely associated with the donor’s age and egg quality than with the recipient’s age. Clinic-specific donor-cycle results should still be reviewed using consistent definitions and denominators.
How to Compare IVF Success Rates Between Clinics
Prospective international patients should evaluate published clinic percentages against a six-point clinical framework:
1. Outcome Metric: Is the figure reporting initial pregnancy detection (hCG) or verified live birth?
2. Denominator: Is the calculation per cycle started, per egg retrieval, or per embryo transfer?
3. Donor Inclusion: Are donor-assisted cycles grouped together with autologous (own egg) cycles?
4. Age Stratification: Are figures broken down into standard medical age bands?
5. Sample Size & Timeframe: Over what duration were the statistics gathered and across how many total cycles?
6. Independent Verification: Are statistics reported under established regulatory registries (e.g., HFEA or national health registries)?
Preimplantation Genetic Testing for Aneuploidy (PGT-A)
Preimplantation Genetic Testing for Aneuploidy (PGT-A) is an optional treatment add-on where blastocyst biopsies are screened for chromosomal abnormalities before transfer. Based on HFEA clinical guidance, PGT-A may reduce miscarriage risk for specific patient cohorts depending on individual medical history. However, reducing miscarriage risk does not necessarily increase the overall chance of a live birth per cycle started, and PGT-A may reduce the number of embryos considered available for transfer after testing. Treatment suitability must be assessed individually by a fertility specialist.
Sources and Methodology
Evidence-based guidelines and comparative statistical benchmarks in this guide are informed by primary regulatory sources:
• HFEA Guide: Choosing a Fertility Clinic — Independent advice on evaluating clinic data.
• HFEA Fertility Treatment 2024 Trends & Figures — Official UK age-stratified birth-rate data; 2024 outcomes are noted as preliminary.
• HFEA PGT-A Add-On Evidence Summary — Clinical summary of chromosomal screening.
Methodology Note: Published national and regional averages serve an educational purpose and cannot determine an individual patient's probability of success. Personal success probabilities require comprehensive evaluation by a qualified reproductive endocrinologist.
Frequently Asked Questions
What is the difference between pregnancy rate and live-birth rate?+
Why can't IVF success rates between clinics be compared directly?+
Is PGT-A genetic screening suitable for all patients?+
How are Meva Clinic's IVF treatment pathways structured?+
How long do I need to stay abroad for IVF treatment?+
Reviewed by
Meva Clinic Medical Review Board
Clinical Governance & Specialist Pathway Standards
This page has been reviewed under Meva Clinic’s specialist medical review pathway. Final treatment suitability, operating physician assignment, surgical planning, and medical decisions are confirmed only after medical history review, in-person consultation, diagnostic tests, anesthesia evaluation, and doctor availability.
Ready for a deeper evaluation?
Consult with our board regarding this specific topic.
Partner Hospital Quality & Medical Network Standards
Accreditation and society references relate to selected partner hospitals, provider institutions, or individual partner surgeons where applicable. Meva Clinic coordinates international patient care through licensed healthcare providers and specialist medical partners.